Rejuvenation of peripheral immune cells attenuates Alzheimer’s disease-like pathologies and behavioral deficits in a mouse model
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Immunosenescence contributes to systematic aging and plays a role in the pathogenesis of Alzheimer’s disease (AD). Therefore, the objective of this study was to investigate the potential of immune rejuvenation as a therapeutic strategy for AD. To achieve this, the immune systems of aged APP/PS1 mice were rejuvenated through young bone marrow transplantation (BMT). Single-cell RNA sequencing revealed that young BMT restored the expression of aging- and AD-related genes in multiple cell types within blood immune cells. The level of circulating senescence-associated secretory phenotype proteins was decreased following young BMT. Notably, young BMT resulted in a significant reduction in cerebral Aβ plaque burden, neuronal degeneration, neuroinflammation, and improvement of behavioral deficits in aged APP/PS1 mice. The ameliorated cerebral amyloidosis was associated with an enhanced Aβ clearance of peripheral monocytes. In conclusion, our study provides evidence that immune system rejuvenation represents a promising therapeutic approach for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“transplantation of bone marrow stem cells from young AD mice to old AD mice reversed the expression of ageing-related differentially expressed genes (DEGs), compromised phagocytosis of monocytes, and cognitive impairment.457”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [457]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881 · cited 1×
“Data preprocessing was performed by the Scanpy Python package v.1.8.1 ( 49 ).”
InfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 1×
“2B), and mitochondrial dysfunction is one of the hallmarks of aging ( 11 ).”
From Louvain to Leiden: guaranteeing well-connected communities
Traag, V. A., Waltman, L., & van Eck, N. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41695-z · Cited by 5,635 · cited 1×
“Then, we clustered the data using the Leiden method ( 51 ).”
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Efremova, M., Vento-Tormo, M., Teichmann, S. A., & Vento-Tormo, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0292-x · Cited by 3,449
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · cited 1×
“Numerous studies have extensively examined and confirmed the characteristics of aging microglia ( 26 ), their role in the development of AD ( 27 ), and the effectiveness of interventions targeting aging microglia ( 28 ).”
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citationImmunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“438 Pangrazzi et al. revealed that the expression of molecules responsible for sustaining immune memory in the human BM undergoes age-related alterations.”
Peripheral proteinopathy in neurodegenerative diseases
Xu, B., Lei, X., Yang, Y., Yu, J., Chen, J., Xu, Z., Ye, K., & Zhang, J. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-024-00461-6 · Cited by 37
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
“The accelerated immune ageing in AD mice includes a decline in the expression of genes involved in epigenetic regulation , particularly in monocytes 32 , whereas its reversal by young bone marrow transplantation mitigates epigenetic alterations across various blood cell types 32 .”
InfluentialHudson, H. R., Sun, X., & Orr, M. E. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00519 · Cited by 33
Cognitive impairments in chronic pain: a brain aging framework
Zhao, L., Zhang, L., Tang, Y., & Tu, Y. (2025) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2024.12.004 · Cited by 30
Self-citationNeuroimmune dynamics and brain aging: mechanisms and consequences
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1715045 · Cited by 24
Alzheimer’s disease and age-related macular degeneration: Shared and distinct immune mechanisms
Butovsky, O., & Rosenzweig, N. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.013 · Cited by 22
Guo, X., Liu, H. N., Song, Y., Wang, J., Liu, D., Zheng, Z., Li, J., Li, B., Song, A., He, W., et al. (2026) · MedComm · doi:10.1002/mco2.70497 · Cited by 30
Self-citationZhang, J., Guan, X., & Zhong, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.006 · Cited by 26
Chronological versus immunological aging: Immune rejuvenation to arrest cognitive decline
Basurco, L., Abellanas, M. A., Purnapatre, M., Antonello, P., & Schwartz, M. (2024) · Neuron · doi:10.1016/j.neuron.2024.12.004 · Cited by 18
Neuropathology and neuroinflammation in Alzheimer’s disease via bidirectional lung–brain axis
Lu, J., Li, C., Wang, J., & Wang, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1449575 · Cited by 14
“…increasing recognition of the close functional relationship between the peripheral system and the central nervous system (CNS) (Li et al., 2024; Sun et al., 2024), as the CNS widely communicates with organs in the peripherals, such Lu et al. 10.3389/fnagi.2024.1449575 Frontiers in Aging…”
BackgroundInfluentialSelf-citationAdaptive immunity in the neuroinflammation of Alzheimer’s disease
Liu, H., Chen, Y., Zhang, J., & Chen, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003695 · Cited by 15
“[76,122,123] Hence, there remains a necessity to develop larger-scale, high-resolution, multimodal cellular atlases to elucidate this mechanism.”
Yu, Z., Liu, J., Liu, Z., Liu, X., Tuo, J., Li, J., Tu, Y., Tan, Q., Ma, Y., Bai, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14402 · Cited by 13
“28 BMTapproachenablestherecipient to stably and long-term produce the wanted blood monocytes.”
Self-citationBone marrow B lymphopoiesis accelerates early cerebral amyloid pathology
Zhang, J., Fang, W., Liu, H., Li, R., Zhu, Z., Wu, X., Yao, S., Fu, Y., Li, R. Q., Chen, W., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02419-0 · Cited by 18
“Although few studies have reported the presence of abnormal bone marrow hematopoiesis in AD model mice, 30,33,34 several key questions need to be answered in order to understand how bone marrow in the peripheral compartment communicates with the brain to orchestrate neuroin fl ammation.”
Long‐Term High‐Fat Diet Affected Bone Marrow Microenvironment During Aging at Single‐Cell Resolution
Pang, Y., Zhu, S., Ding, P., Zhang, S., Zhang, Y., Ye, F., Zhang, C., Gao, J., & Yin, J. (2025) · MedComm · doi:10.1002/mco2.70276 · Cited by 8
Trained immunity in acute and chronic neurological diseases
Zhang, S., & Liesz, A. (2026) · eLife · doi:10.7554/elife.106037 · Cited by 7
“…was capable of reversing the cerebral A β plaque burden, neuronal degeneration, neuroinflammation, and behavioral deficits in aged APP/PS1 mice ( Sun et al., 2024b ), revealing a potential central TRIM feature of the bone marrow in AD and their critical role in the development and progression…”
Bond, M. L., Quiroga, I. Y., D’Costa, S., Wu, Y., Bell, J. L., McAfee, J. C., Kramer, N. E., Lee, S., Patrucco, M., Phanstiel, D. H., et al. (2024) · medRxiv · doi:10.1101/2024.09.13.24313654 · Cited by 6
“Moreover, peripheral monocytes and macrophages have been shown to infiltrate AD brains 19 , and complex crosstalk between peripheral and central immune cells has been proposed to contribute to neuroinflammation and disease progression in AD 20,21 .”
BackgroundGut microbiota and aging: current understanding and future perspectives
Lan, M., Ding, H., Cao, Y., Liu, J., Tu, L., Fu, S., & Guo, W. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00499-0 · Cited by 8
“Inflammaging is characterized by increased baseline levels of pro-inflammatory cytokines in the blood, such as IL-6, TNF-α, and CRP [53, 54].”
Self-citationLinzhu, Zhang, J., Fan, W., Su, C., & Jin, Z. (2025) · BMC Neurology · doi:10.1186/s12883-025-04057-z · Cited by 6
Frontiers and hotspots evolution in anti-inflammatory studies for Alzheimer’s disease
Wu, S., Chen, N., & Wang, C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115178 · Cited by 4
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 5
Croese, T., Mummery, C. J., Bregman, N., Bracha, D., Baruch, K., Kertser, A., Raveh, S., Shochat, E., & Schwartz, M. (2026) · Nature Medicine · doi:10.1038/s41591-026-04547-8 · Cited by 4
“Progression is increasingly understood to involve chronic neuroinflammation which, together with other processes such as metabolic and vascular dysfunction, contributes to neurodegeneration and may itself be fueled by age-related decline of the systemic immune system 1–6 .”
Natural Killer Cells in Alzheimer's Disease: From Foe to Friend
Kostić, M. S., Živković, N., Cvetanović, A., Bašić, J., & Stojanović, I. R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70096 · Cited by 4
“Interestingly, APP/PS1 mice also showed a gradual decline in total NK cell numbers with aging and disease progression (Sun et al. 2024).”
Yu, Z., Liu, X., Li, Q., Tuo, J., Tan, Q., Liu, Z., Yuan, Z., Zeng, R., Zhao, Y., Li, J., et al. (2025) · Aging Cell · doi:10.1111/acel.70205 · Cited by 5
“Prior studies have demonstrated that very few blood-immune cells infiltrated into the brain after BMT unless microglia are ablated prior to BMT; thus, we reason that the local genotype of microglia did not change (Sun et al. 2024; Xu et al. 2020; Yu et al. 2025).”
Self-citationAlzheimer’s disease causes bone marrow myelopoiesis dysfunctionPreprint
Abellanas, M. A., Basurco, L., Purnapatre, M., Burgaletto, C., Castellani, G., Colaiuta, S. P., Ramos, J. M. P., Ibraheem, A., Murad, S., Antonello, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.06.680030 · Cited by 3
Immune rejuvenation — a potential AD therapy
Wood, H. B. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00996-2 · Cited by 2
Xu, R., & Gao, Y. (2025) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000546762 · Cited by 1
“TNF-β may be involved in modulating the differentiation and functions of immune cells such as T cells and B cells, ensuring that the immune response remains at an appropriate level [45, 46].”
Immune cells in cerebral small vessel disease: Emerging roles and potential targeting therapies
Zhan, Y., Wang, Y., Bai, M., Feng, J., Wei, J., & Wang, J. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00858 · Cited by 1
Self-citationBlood as the mirror and modulator of aging: mechanistic insights and rejuvenation strategies
Kim, E., Kang, J. S., & Yang, Y. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01688-1 · Cited by 2
“A study that rejuvenated peripheral immune cells in aged Alzheimer ’ s model mice by transplanting young myeloid cells showed mitigation of cerebral amyloid pathology and cognitive decline, suggesting that immune rejuvenation can contribute to the improvement of neurodegenerative diseases 36 .”
Is amyloid beta peptide a driver of inflammaging?
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. А. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103280 · Cited by 1
Functional Proteins/Peptides Targeting to Clear Amyloid‐β for Alzheimer's Disease Therapy
Gao, Z., Hou, R., & Qian, C. (2025) · ChemBioChem · doi:10.1002/cbic.202400912
Xue, L., Yang, Y.-Q., Du, R., Gan, Z., Zhao, Y., Wang, W., Bi, N., Wang, Q., Wang, T., & Xiong, L. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf193 · Cited by 1
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Self-citationGautam, A. S., & Singh, R. K. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70721
“The activation of the peripheral immune system and the presence of Aß suggest the interaction between these two that leads to the generation of pro‐inflammatory cytokines [9–11, 47, 48].”
Cai, J., Zhang, J., Ning, Y., Zhang, J., Xu, T., Liu, M., Wang, K., & Chen, H. (2026) · Aging Cell · doi:10.1111/acel.70400
“A recent study demonstrates that peripheral immune cells can be rejuvenated through transplanting young bone marrow cells in aged APP/PS1 mice thereby improving Alzheimer's disease-like pathologies and behavioral deficits (Sun et al. 2024).”
How molecular mechanisms of aging drive Alzheimer's disease pathology
Chang, J., Liu, T., Cheng, X., & Wei, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112426
Addressing population aging: Innovative approaches to aging research in China
Jingyi, L. I., Lei, J., Chu, Q., Zhang, W., Song, M., Peng, Y., & Guang-Hui, L. I. U. (2026) · Zhongguo Kexueyuan yuankan · doi:10.3724/j.issn.1000-3045.20240309005
Xu, L., Wei, Z., Wei, A., Wang, K., & Wang, T. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153967 · Cited by 1
Lv, Y., Yi, J., You, D., Yan, Y., Tang, B., Qiu, Y., & Wu, Y. J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03906-z · Cited by 1
“While systemic bone marrow interventions such as young hematopoietic stem cell transplantation can reverse age-related cognitive decline [3] and ameliorate Alzheimer’s pathology in models [4, 5], such approaches introduce systemic variables that obscure local mechanisms.”
Jiang, Q., & Yan-Jiang, W. A. N. G. (2026) · Shengming kexue · doi:10.3724/cbls.2026100
Self-citationAbellanas, M. A., Basurco, L., Purnapatre, M., Burgaletto, C., Castellani, G., Colaiuta, S. P., Ramos, J. M. P., Ibraheem, A., Murad, S., Antonello, P., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02417-7 · Cited by 3
Yang, Z., Xiao, Z., Huang, B., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955233 · Cited by 1
Huang, S., Zhang, Z., Xia, J., Deng, M., Chen, F., Wang, M., Fei, Y., Jiang, Z., Lu, C., Fu, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71896
Xiang, X., Li, T., Feng, Z., Yang, J., Gong, Z., Wang, L., Wang, L., & Zhang, W. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71201
“Established AD-risk genes [41] were expressed predominantly in sepsis-derived CMPs and, by contrast, in AD-derived terminal DCs (Figure S4E; Table S8), and epigenetic modulators [42] were lower in sepsis-derived DCs yet higher in AD-derived DCs and platelets (Figure S4F).”
Shi, H., Zhao, Y., Wei, Z., Yan-jiang, W., & Bu, X.-L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.09.009
Self-citation
Metadata
- Authors
- Sun, P.-Y., Liu, J., Hu, J.-N., Tu, Y.-F., Jiang, Q., Jia, Y.-J., Sun, H.-L., Chen, S.-H., Xin, J.-Y., Yu, Z.-Y., Liu, Z.-H., Tan, C.-R., Zeng, G.-H., Shi, A.-Y., Liu, Y.-H., Bu, X.-L., Wang, Y.-J., & Wang, J.
- Affiliations
- Army Medical University (CN)
- Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
- North Sichuan Medical University (CN)
- Corresponding author
- Sun, Pu-Yang
- Liu, Jie
- Hu, Jian-Ni
- Tu, Yun-Feng
- Wang, Yan-Jiang
- Wang, Jun
- ORCID
- Venue
- Science Advances
- Published
- 2024-05-31
- Volume
- 10
- Issue
- 22
- Pages
- eadl1123-eadl1123
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC11135428
- OpenAlex
- W4399118372
- Cited by
- 46
- References
- 55
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 7
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Antioxidants, Aging, Portulaca oleracea
- Keywords
- Alzheimer's disease, immunosenescence, immune rejuvenation, bone marrow transplantation, APP/PS1 mice, senescence-associated secretory phenotype, amyloid-beta clearance, cerebral amyloidosis, neuroinflammation, peripheral blood monocytes, aging, behavioral deficits, single-cell RNA sequencing
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Disease Models, Animal, Humans, Mice, Transgenic, Monocytes, Rejuvenation, Bone Marrow Transplantation, Amyloid beta-Peptides, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.